MMD
5-(7-Methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine
Find entries where: MMD
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 5-(7-Methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine |
Identifiers | 5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine |
Formula | C15 H19 N7 O3 S |
Molecular Weight | 377.421 |
Type | NON-POLYMER |
Isomeric SMILES | CS(=O)(=O)N1CCc2c1nc(nc2c3cnc(nc3)N)N4CCOCC4 |
InChI | InChI=1S/C15H19N7O3S/c1-26(23,24)22-3-2-11-12(10-8-17-14(16)18-9-10)19-15(20-13(11)22)21-4-6-25-7-5-21/h8-9H,2-7H2,1H3,(H2,16,17,18) |
InChIKey | JEGHXKRHKHPBJD-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 45 |
Chiral Atom Count | 0 |
Bond Count | 48 |
Aromatic Bond Count | 13 |
Drug Info: DrugBank
DrugBank ID | DB13051 |
---|---|
Name | CH-5132799 |
Groups | investigational |
Description | CH5132799 has been used in trials studying the treatment of Solid Tumors. |
Synonyms | CH-5132799 |
Categories |
|
CAS number | 1007207-67-1 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1684984 |
PubChem | 49784945 |
ChEMBL | CHEMBL1684984 |
CCDC/CSD | VEJNOQ |